Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Cost Savings on Generic Drugs: Transparent Pric...
By
HEOR Staff Writer
June 18, 2024
Introduction Through its transparent, online direct-to-consumer pharmacy model, the Mark Cuban Cost Plus Drug Company (MCCPDC) has made substantial progress in the provisi...
Brucellosis Control in Armenia: A Holistic Approach
Introducing GRACE for Patient-Centric Care
Universal Early Parenting Programmes: Unraveling the Cost-Effectiveness
Rethinking Health State Valuation: Moving Beyond ‘Dead’ as an Anchor
Europe MedTech Sector: Opportunities and Challenges
The Impact of Time Horizons on QALY Calculations in Healthcare
Making Better Choices in Diabetes Care With Multi-criteria Decision Making (M...
HTA in Essential Health Benefit Package Design
Healthcare Decision-Making with MCDA Framework: The Saudi Arabian Perspective
Prevention is Better Than Cure: The Costs of the Pandemic Accord
Health Technology Assessment in South Africa: Towards NHI
Economic Evaluations for Dementia Interventions
« Previous
1
…
30
31
32
33
34
…
54
Next »